FDA Inspection 1086433 — Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
The FDA completed an inspection of Shandong Ruiying Pioneer Pharmaceutical Co., Ltd on March 22, 2019 in Heze. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 22, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Heze (China)